777 replies to this topic

[ImmInst]

BioTime Inc (BTX) Jumps 6.35% on March 21
Equities.com - 2 hours ago

BioTime Inc (BTX) was among the biggest gainers on the Russell 2000 for Monday March 21 as the stock popped 6.35% to $2.68, representing a gain of $0.16 per share.

View the full article

[ImmInst]

BioTime Inc.: Asterias Biotherapeutics to Report Fourth Quarter and Full Year ...
The Wall Street Transcript - 2 hours ago

FREMONT, Calif., March 23, 2016 /PRNewswire/ -- Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a biotechnology company focused on the emerging field of regenerative medicine, today announced that it will release fourth quarter and full year 2015 ...

View the full article

[ImmInst]

What's Next for BioTime, Inc. After Today's Huge Decline?
Business Standard Tribune - 16 hours ago

The stock of BioTime, Inc. (NYSEMKT:BTX) is a huge mover today! The stock decreased 5.97% or $0.16 on March 23, hitting $2.52.

View the full article

[ImmInst]

Big Movers: BioTime, Inc. (NYSEMKT:BTX), Peak Resorts, Inc. (NASDAQ:SKIS ...
Stock Transcript - 5 hours ago

BioTime, Inc. (NYSE MKT:BTX) announced that it will host a conference call on Thursday, March 31, to update investors on the Company's recent accomplishments and objectives for the remainder of 2016.

View the full article

[ImmInst]

BioTime Inc (BTX) Drops 6.67% on March 23
Equities.com - 2 hours ago

BioTime Inc (BTX) was one of the Russell 2000's biggest losers for Wednesday March 23 as the stock slid 6.67% to $2.52, a loss of $-0.18 per share.

View the full article

[ImmInst]

BIOTIME INC (NYSE:BTX) rated an average of Strong Buy by 2 of analysts
Hints News Network - 28 minutes ago

BIOTIME INC (NYSE:BTX) received a 'Strong Buy' rating on average from equities analysts who cover the company. The rating was compiled from from the 2 investment firms that maintain analyst coverage on the company.

View the full article

[ImmInst]

HC Recent Stock News: BioTime (BTX), Carbylan Therapeutics (CBYL), Cymabay ...
share market updates (press release) - 8 hours ago

Shares of BioTime, Inc. (NYSE:BTX) ended Thursday session in red amid volatile trading. The shares closed down -0.01 points or -0.40% at $2.51.

View the full article

[ImmInst]

New Consensus Analyst Ratings Released for BIOTIME INC (NYSE:BTX)
Hints News Network - 2 hours ago

Analysts have issued a 'Strong Buy' rating for BIOTIME INC (NYSE:BTX), according to data recently reviewed by Zacks.

BioTime (BTX) Short Interest Disclosure - The Sussex Pilot

View the full article

[ImmInst]

BioTime Inc (BTX) Jumps 5.53% on March 29
Equities.com - 1 hour ago

BioTime Inc (BTX) was among the biggest gainers on the Russell 2000 for Tuesday March 29 as the stock popped 5.53% to $2.67, representing a gain of $0.14 per share.

View the full article

[ImmInst]

BioTime Inc.: Asterias Biotherapeutics Reports Fourth Quarter and Full Year ...
The Wall Street Transcript - 3 hours ago

FREMONT, Calif., March 29, 2016 /PRNewswire/ -- Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a biotechnology company focused on the emerging field of regenerative medicine, today reported financial results for the fourth quarter and year ended ...

View the full article

[ImmInst]

Analyst's Earnings Roundup: BioTime, Inc. (NYSEMKT:BTX)
The Point Review - 35 minutes ago

Wall Street analysts are predicting that BioTime, Inc. (NYSEMKT:BTX) will report earnings per share of $-0.16 in their quarterly report.

View the full article

[ImmInst]

BioTime, Inc. (NASDAQ:BTX) To Report Earnings Tomorrow
Share Trading News - 12 hours ago

The biggest institutional shareholders in BioTime, Inc. include BROADWOOD CAPITAL Inc which owns 22 million shares in the company valued at $89.64 million.

View the full article

[ImmInst]

Will BioTime, Inc. Go Down Anytime Soon?
SmallCapWired.com - 12 minutes ago

The stock of BioTime, Inc. (NYSEMKT:BTX) is a huge mover today! The stock increased 3.75% or $0.1 during the last trading session, hitting $2.77.

BioTime, Inc. (NASDAQ:BTX) To Report Earnings Tomorrow - Share Trading News
Broadwood Capital Inc buys $55.1 Million stake in BioTime (BTX) - The Sussex Pilot

View the full article

[ImmInst]

BioTime, Inc. (NASDAQ:BTX) To Release Earnings
Risers & Fallers - 3 hours ago

Analysts await BioTime, Inc. (NASDAQ:BTX) to report earnings on Mar, 31 for the fiscal quarter ending Dec 2015. At the moment 2 analysts are watching BioTime, Inc. (NASDAQ:BTX), 1 rate it “Buy”, 1 “Outperform”, 0 “Underperform”, 0 “Sell”, while 0 “Hold”.

View the full article

[ImmInst]

Host a Conference Call: BioTime, Inc. (BTX)
share market updates (press release) - 6 hours ago

Shares of BioTime, Inc. (NYSEMKT:BTX) ended Wednesday session in green amid volatile trading. The shares closed up +0.10 points or 3.75% at $2.77 with 239,878.00 shares getting traded.

View the full article

[ImmInst]

BioTime Inc.: Asterias Biotherapeutics Announces Record Date for Distribution ...
The Wall Street Transcript - 4 hours ago

FREMONT, Calif., March 31, 2016 /PRNewswire/ -- Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a biotechnology company focused on the emerging field of regenerative medicine, today announced that its Board of Directors has set the record date for its ...

View the full article

[ImmInst]

Financial Results: BioTime, Inc. (BTX)
share market updates (press release) - Mar 29, 2016

Shares of BioTime, Inc. (NYSEMKT:BTX) ended Thursday session in green amid volatile trading. The shares closed up +0.10 points or 3.61% at $2.87 with 4250 shares getting traded.

View the full article

[ImmInst]

Research Analysts Issue Forecasts for BioTime, Inc.'s Q1 2016 Earnings (BTX)
The Vista Voice - 2 hours ago

BioTime logo BioTime, Inc. (AMEX:BTX) - Research analysts at Oppenheimer issued their Q1 2016 EPS estimates for BioTime in a research report issued to clients and investors on Friday, Zacks Investment Research reports.

Company Shares of BioTime (NYSEMKT:BTX) Rally 16.34% - Street Edition

View the full article

[ImmInst]

Analysts Offer Predictions for BioTime, Inc.'s Q1 2016 Earnings (BTX)
Financial Market News - 24 minutes ago

BioTime logo BioTime, Inc. (AMEX:BTX) - Equities research analysts at Oppenheimer issued their Q1 2016 earnings per share (EPS) estimates for BioTime in a research note issued on Friday, Zacks Investment Research reports.

View the full article

[ImmInst]

BioTime Inc (BTX) is Trading Higher on Unusual Volume for April 04
Equities.com - 2 hours ago

BioTime Inc (BTX) experienced unusually high volume on Apr. 04, as the stock gained 7.88% to a closing price of $3.15. The stock saw 378,190 shares trade hands over the course of the day on 1,179 trades.

BioTime Co-CEO Dr. Michael West to Present at Stem Cells in Drug Discovery ... - Business Wire (press release)

View the full article

[ImmInst]

BioTime Inc (BTX) is Trading Higher on Unusual Volume for April 04
Equities.com - 6 hours ago

BioTime Inc (BTX) experienced unusually high volume on Apr. 04, as the stock gained 7.88% to a closing price of $3.15. The stock saw 378,190 shares trade hands over the course of the day on 1,179 trades.

View the full article

[ImmInst]

BioTime Inc (BTX) is Trading Higher on Unusual Volume for April 04
Equities.com - 9 hours ago

BioTime Inc (BTX) experienced unusually high volume on Apr. 04, as the stock gained 7.88% to a closing price of $3.15. The stock saw 378,190 shares trade hands over the course of the day on 1,179 trades.

2 Analysts Rate BIOTIME INC (NYSE:BTX) an Average of Strong Buy - Hints News Network

View the full article

[ImmInst]

BioTime Inc. (BTX) Receives New Coverage from Analysts at Chardan Capital
Web Breaking News - 3 hours ago

BioTime Inc. logo Chardan Capital began coverage on shares of BioTime Inc. (NYSEMKT:BTX) in a research note released on Thursday morning, Market Beat Ratings reports.

Consonance Capital Management Lp Exits Position in BioTime (BTX) - The Sussex Pilot

View the full article

[ImmInst]

Form 4 BIOTIME INC For: Apr 07 Filed by: WEST MICHAEL D
StreetInsider.com - 1 hour ago

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). 1. Name and Address of Reporting Person *. WEST MICHAEL D. (Last), (First), (Middle). 1010 ATLANTIC AVENUE. SUITE 102. (Street) ...

View the full article

[ImmInst]

BioTime, Inc. (BTX) Research Coverage Started at Chardan Capital
The Vista Voice - 1 hour ago

Chardan Capital assumed coverage on shares of BioTime, Inc. (NYSEMKT:BTX) in a report published on Thursday, ARN reports.

View the full article

[ImmInst]

Watch List: athenahealth, Inc. (NASDAQ:ATHN), BioTime, Inc. (NYSEMKT:BTX ...
KC Register - 2 hours ago

athenahealth, Inc. (NASDAQ:ATHN) reported that, its bottom line climbed to $13.41 million, or $0.34 per share. This was up from $9.14 million, or $0.24 per share, in last year's first quarter.

View the full article

[ImmInst]

How Analysts Feel About BioTime, Inc. After Today's Huge Increase?
The Post - 1 hour ago

The stock of BioTime, Inc. (NYSEMKT:BTX) is a huge mover today! The stock increased 6.53% or $0.19 on May 2, hitting $3.1.

View the full article

[ImmInst]

BioTime Inc (BTX) Jumps 6.16% on May 02
Equities.com - 7 hours ago

BioTime Inc (BTX) was among the biggest gainers on the Russell 2000 for Monday May 02 as the stock popped 6.16% to $3.10, representing a gain of $0.18 per share.

View the full article

[ImmInst]

Is Selling Stock Like BioTime, Inc. After Such Decline Winning Strategy?
B.O.D.Y Confidential - 2 hours ago

The stock of BioTime, Inc. (NYSEMKT:BTX) is a huge mover today! The stock decreased 4.96% or $0.14 on May 6, hitting $2.68.

View the full article

[ImmInst]

BRIEF-Biotime Inc Qtrly loss per common share $0.19
Reuters - 1 hour ago

May 10 Biotime Inc. * Qtrly loss per common share $0.19. * Q1 earnings per share view $-0.14, revenue view $1.4 million -- Thomson Reuters I/B/E/S.

View the full article